APA (7th ed.) Citation

Kim, T., Jang, T. W., Choi, C. M., Kim, M., Lee, S. Y., Chang, Y. S., . . . Oh, H. (2023). Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non--Small Cell Lung Cancer: Updated Analysis of the RESET Study. Cancer Research & Treatment, 55(4), 1152. https://doi.org/10.4143/crt.2023.493

Chicago Style (17th ed.) Citation

Kim, Taeyun, et al. "Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non--Small Cell Lung Cancer: Updated Analysis of the RESET Study." Cancer Research & Treatment 55, no. 4 (2023): 1152. https://doi.org/10.4143/crt.2023.493.

MLA (9th ed.) Citation

Kim, Taeyun, et al. "Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non--Small Cell Lung Cancer: Updated Analysis of the RESET Study." Cancer Research & Treatment, vol. 55, no. 4, 2023, p. 1152, https://doi.org/10.4143/crt.2023.493.